CTNI-33. CSNO2012001 STUDY: A PHASE III TRIAL ON ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA IN NEWLY DIAGNOSED HIGH-GRADE GLIOMAS

Authors: ZhongPing Chen, Chengcheng Guo, JianGen Chen

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.298

Source: Full article


Abstract

Abstract